Prostate Cancer Outcomes – Compare & Reduce Variation in Prostate Cancer Centers certified by the German Cancer Society; subproject MID-EPIC-D

Recruiting

• Conditions: C61; Malignant neoplasm of prostate

• Registration Number: DRKS00010774
• Lead Sponsor: Deutsche Krebsgesellschaft

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-09-08
• Results First Posted: 2019-09-24
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Male
• Target Recruitment: 70000

Inclusion Criteria

Patients with localized prostate cancer

Exclusion Criteria

insufficient language skills to fill out questionnaire

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. (relative) survival, 2. disease-free survival, 3. PROs: 3a. incontinence, 3b. irritative/obstructive, 3c. gastrointestinal, 3d. sexuality, 3e. hormonal, and 3f. libido, collected after 6 and 12 months, then annually

Secondary Outcome Measures

Name	Time	Method
formative evaluation of data collection method